XASXPHX
Market cap15mUSD
Oct 30, Last price
0.04AUD
Name
Corum Group Ltd
Chart & Performance
Profile
Corum Group Limited, together with its subsidiaries, operates as a technology and software development company in Australia. The company operates through Health Service segment. It develops and distributes business software for the pharmacy industry with emphasis on an electronic ordering gateway; point-of-sale and pharmaceutical dispensing software, multi-site retail management, and computer hardware and support services. The company was formerly known as Cosmos Limited and changed its name to Corum Group Limited in November 2006. Corum Group Limited was incorporated in 1950 and is headquartered in Sydney, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | |||||||||
Revenues | 6,018 -49.52% | 11,922 -6.13% | |||||||
Cost of revenue | 4,137 | 9,450 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 1,881 | 2,472 | |||||||
NOPBT Margin | 31.26% | 20.73% | |||||||
Operating Taxes | 164 | 280 | |||||||
Tax Rate | 8.72% | 11.33% | |||||||
NOPAT | 1,717 | 2,192 | |||||||
Net income | (1,051) -517.06% | 252 -76.90% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 32 | 303 | |||||||
Long-term debt | 32 | 349 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 1,010 | 1,411 | |||||||
Net debt | (12,742) | (5,255) | |||||||
Cash flow | |||||||||
Cash from operating activities | 2,193 | ||||||||
CAPEX | (3,359) | (3,975) | |||||||
Cash from investing activities | (3,572) | (3,639) | |||||||
Cash from financing activities | (325) | (361) | |||||||
FCF | 2,273 | 2,380 | |||||||
Balance | |||||||||
Cash | 12,806 | 5,759 | |||||||
Long term investments | 148 | ||||||||
Excess cash | 12,505 | 5,311 | |||||||
Stockholders' equity | 22,211 | 23,203 | |||||||
Invested Capital | 10,748 | 19,629 | |||||||
ROIC | 11.30% | 11.59% | |||||||
ROCE | 7.75% | 9.52% | |||||||
EV | |||||||||
Common stock shares outstanding | 596,757 | 596,757 | |||||||
Price | 0.04 8.82% | 0.03 -60.92% | |||||||
Market cap | 22,080 8.82% | 20,290 -57.02% | |||||||
EV | 9,338 | 15,035 | |||||||
EBITDA | 1,881 | 4,647 | |||||||
EV/EBITDA | 4.96 | 3.24 | |||||||
Interest | 54 | 71 | |||||||
Interest/NOPBT | 2.87% | 2.87% |